Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife
Open Access
- 5 March 2023
- journal article
- research article
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 21, 97-113
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (LP180101251)
This publication has 255 references indexed in Scilit:
- Natural Variation in a Chloride Channel Subunit Confers Avermectin Resistance in C. elegansScience, 2012
- Comparative evaluation of systemic drugs for their effects against Anopheles gambiaeActa Tropica, 2012
- Principles of activation and permeation in an anion-selective Cys-loop receptorNature, 2011
- Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)Parasitology Research, 2010
- Sarcoptes mite epidemiology and treatment in African buffalo (Syncerus caffer) calves captured for translocation from the Kafue game management area to game ranchesBMC Veterinary Research, 2010
- Moxidectin: a review of chemistry, pharmacokinetics and use in horsesParasites & Vectors, 2009
- Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in DrosophilaNature Neuroscience, 2008
- GABAA Receptor RDL Inhibits Drosophila Olfactory Associative LearningNeuron, 2007
- Chloride channels as tools for developing selective insecticidesArchives of Insect Biochemistry and Physiology, 2003
- Ivermectin, an Unconventional Agonist of the Glycine Receptor Chloride ChannelJournal of Biological Chemistry, 2001